These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 22875137)
1. A hexanuclear gadolinium-organic octahedron as a sensitive MRI contrast agent for selectively imaging glucosamine in aqueous media. He C; Wu X; Kong J; Liu T; Zhang X; Duan C Chem Commun (Camb); 2012 Sep; 48(74):9290-2. PubMed ID: 22875137 [TBL] [Abstract][Full Text] [Related]
2. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Caravan P Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145 [TBL] [Abstract][Full Text] [Related]
3. Ab initio simulation of a gadolinium-based magnetic resonance imaging contrast agent in aqueous solution. Pollet R; Marx D J Chem Phys; 2007 May; 126(18):181102. PubMed ID: 17508784 [TBL] [Abstract][Full Text] [Related]
4. Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water. Bonnet CS; Fries PH; Crouzy S; Delangle P J Phys Chem B; 2010 Jul; 114(26):8770-81. PubMed ID: 20552972 [TBL] [Abstract][Full Text] [Related]
5. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
6. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes. Terreno E; Boffa C; Menchise V; Fedeli F; Carrera C; Castelli DD; Digilio G; Aime S Chem Commun (Camb); 2011 Apr; 47(16):4667-9. PubMed ID: 21409237 [TBL] [Abstract][Full Text] [Related]
7. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Werner EJ; Datta A; Jocher CJ; Raymond KN Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates. Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075 [TBL] [Abstract][Full Text] [Related]
9. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents. Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814 [TBL] [Abstract][Full Text] [Related]
10. Lanthanides in magnetic resonance imaging. Bottrill M; Kwok L; Long NJ Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149 [TBL] [Abstract][Full Text] [Related]
11. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
12. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621 [TBL] [Abstract][Full Text] [Related]
13. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
14. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging. Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022 [TBL] [Abstract][Full Text] [Related]